Amgen’s Latest Clinical Study: A Potential Game-Changer in Lung Cancer Treatment

1 month ago 24

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher Biotherapeutics, Inc., is conducting a Phase 1b stu...

1. Homepage
2. Lung Cancer
3. Amgen’s Latest Clinical Study: A Potential Game-Changer in Lung Cancer Treatment